Abstract P3-11-01: Oncolytic herpes simplex virus immunovirotherapy eradicates breast cancer and prevents tumor relapse - KIVIRID

Abstract P3-11-01: Oncolytic herpes simplex virus immunovirotherapy eradicates breast cancer and prevents tumor relapse

Authors: Hong-My Nguyen, Othon Almanza, Dipongkor Saha

Published: 2022-03-08

DOI: 10.1158/1538-7445.sabcs21-p3-11-01

Source: Full article

Abstract

Abstract